LeafNLP Demos
Back to explore

Report #2868834

Received Oct 27, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Sep 29, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALS1D4J9LIM

Symptoms (1)

Exposure during pregnancy

Symptom narrative

Vaccine exposure during pregnancy; This non-serious prospective pregnancy case was reported by a other health professional via sales rep and described the occurrence of vaccine exposure during pregnancy in a 35-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number D4J9L, expiry date 11-JUL-2027) for prophylaxis. On 29-SEP-2025, the patient received the 1st dose of Boostrix (intramuscular). On an unknown date, an unknown time after receiving Boostrix, the patient experienced vaccine exposure during pregnancy (Verbatim: Vaccine exposure during pregnancy). The outcome of the vaccine exposure during pregnancy was not applicable. Pregnancy exposure: Pregnancy Exposure (Boostrix): To mother in third trimester Pregnancy Details (Neonate 1): Pregnancy Outcome: Lost to follow up Delivery Notes: The patient was 33 weeks pregnant at the time of the event onset. Additional Information: GSK Receipt Date: 07-OCT-2025 A healthcare professional reported that a 35-year-old female patient, who was 33 weeks pregnant, received the vaccine, resulting in vaccine exposure during pregnancy.